Skip to main navigation Skip to search Skip to main content

A randomized assessor-blinded comparison of low-irradiance and conventional-irradiance photodynamic therapy for superficial basal cell carcinoma and Bowen disease

  • S.H. Ibbotson
  • , J. Ferguson
  • , H. Moseley
  • , I.D.W. Samuel
  • , A. Lesar
  • , R.S. Dawe

Research output: Contribution to journalLetterpeer-review

Abstract

The inconvenience and pain of hospital-based photodynamic therapy (PDT) is sometimes limiting.1 We developed very low irradiance LEDs for ambulatory PDT. Preliminary studies showed this to be convenient and relatively painless.1-4 Here we evaluate the Ambulight® device (Ambicare Health Ltd) in a randomised controlled assessor-blinded study comparing low irradiance ambulatory PDT (APDT) with conventional PDT (CPDT) for superficial basal cell carcinoma (SBCC) and Bowen's disease (BD) (lesions ≤2cm).
Original languageEnglish
Article number20762
Number of pages3
JournalBritish Journal of Dermatology
VolumeEarly View
Early online date24 Nov 2021
DOIs
Publication statusE-pub ahead of print - 24 Nov 2021

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Fingerprint

Dive into the research topics of 'A randomized assessor-blinded comparison of low-irradiance and conventional-irradiance photodynamic therapy for superficial basal cell carcinoma and Bowen disease'. Together they form a unique fingerprint.

Cite this